Aprea Therapeutics APRE
NASDAQ APRE
$0.52 -0.02 (-3.70%)
At close: Oct 23, 2026 · 4:00 PM EDT

Aprea Therapeutics (APRE) Cash from Investing Activities (2018 - 2024)

Updated

Aprea Therapeutics (APRE) recorded Cash from Investing Activities of -$15,478 in FY2024, compared with -$93,093 in FY2023.

Analysis

Aprea Therapeutics (APRE) Cash from Investing Activities (2018 - 2024) Analysis & Trends

Starting with FY2018, Aprea Therapeutics' Cash from Investing Activities history includes 5 years.

  • The FY2024 figure is the highest annual Cash from Investing Activities since FY2018.
  • Per Business Quant data, APRE's Cash from Investing Activities was -$93,093 in FY2023 and -$25,709 in FY2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn -15.40 Bn
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn -2.71 Bn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn -1.20 Bn
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn -5.60 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn -3.11 Bn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn -2.91 Bn
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn -569.00 Mn
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn -10.35 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn 2.11 Bn
10 Aprea Therapeutics 27.81 Mn -88.24 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2024 -7,500.00
Mar 31, 2024 -7,978.00
Dec 31, 2023 -7,150.00
Dec 31, 2020 -16,290.00
Sep 30, 2020 725.00
Jun 30, 2020 2,021.00
Mar 31, 2020 -12,165.00
Dec 31, 2019 -14,466.00
Sep 30, 2019 -10,246.00
Dec 31, 2018 804.00
API Access

Aprea Therapeutics Cash from Investing Activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-investing-activities&ticker=APRE&period=max&api_key=YOUR_API_KEY